{"entity":{"type":"insider","cik":"0001578074","url":"/insider/0001578074","json_url":"/insider/0001578074.json","name":"Kronenfeld Mark A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2013-09-13","last":"2023-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Kronenfeld Mark A.","source":"filing","n_filings":7,"first_seen":"2013-09-13","last_seen":"2023-06-12"}],"transactions":[{"id":8043078,"accession":"0001209191-23-036270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-036270","line_url":"/filing/0001209191-23-036270#line-2","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":37.04,"price_display":"37.04","price_state":"stated","total_value":555600.0,"total_display":"555,600.00","total_whole":"555,600","shares_owned_after":17897.0,"shares_owned_after_display":"17,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":7946146,"accession":"0001209191-19-018092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-018092","line_url":"/filing/0001209191-19-018092","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":38.96705882352941,"price_display":"38.97","price_state":"stated","total_value":66244.0,"total_display":"66,244.00","total_whole":"66,244","shares_owned_after":10277.0,"shares_owned_after_display":"10,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-06","filed_date":"2019-03-08","scope":"insider","n_lines":2},{"id":6142013,"accession":"0001209191-18-048951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-048951","line_url":"/filing/0001209191-18-048951#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":44.6112,"price_display":"44.61","price_state":"stated","total_value":44611.2,"total_display":"44,611.20","total_whole":"44,611","shares_owned_after":8577.0,"shares_owned_after_display":"8,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-30","scope":"insider"},{"id":5039016,"accession":"0001209191-17-060479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-060479","line_url":"/filing/0001209191-17-060479#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":41.6025,"price_display":"41.60","price_state":"stated","total_value":41602.5,"total_display":"41,602.50","total_whole":"41,603","shares_owned_after":6795.0,"shares_owned_after_display":"6,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-13","scope":"insider"},{"id":2470203,"accession":"0001209191-16-126651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126651","line_url":"/filing/0001209191-16-126651#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":46.95,"price_display":"46.95","price_state":"stated","total_value":42255.0,"total_display":"42,255.00","total_whole":"42,255","shares_owned_after":2950.0,"shares_owned_after_display":"2,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":6673915,"accession":"0001181431-14-035486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-035486","line_url":"/filing/0001181431-14-035486#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850.0,"shares_display":"850","price_per_share":90.48,"price_display":"90.48","price_state":"stated","total_value":76908.0,"total_display":"76,908.00","total_whole":"76,908","shares_owned_after":1850.0,"shares_owned_after_display":"1,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":5027225,"accession":"0001181431-13-049044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-049044","line_url":"/filing/0001181431-13-049044#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001578074","owner_name":"Kronenfeld Mark A.","owner_display_name":"Kronenfeld Mark A.","owner_url":"/insider/0001578074","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":37.01,"price_display":"37.01","price_state":"stated","total_value":37010.0,"total_display":"37,010.00","total_whole":"37,010","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-11","filed_date":"2013-09-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Director","n_filings":7,"first_seen":"2013-09-13","last_seen":"2023-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578074","retrieved_at":"2026-08-23T02:26:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}